SPY323.50+0.86 0.27%
DIA268.10+0.52 0.19%
IXIC10,672.27+39.28 0.37%

DnaNudge Selects Benchmark For Volume Manufacturing Of Rapid, Lab-Free COVID-19 Testing System

TEMPE, Ariz., Sept. 9, 2020 /PRNewswire/ --Benchmark Electronics, Inc. (NYSE:BHE), a global provider of engineering, design, and manufacturing services, and consumer genetic testing pioneersDnaNudge,today

· 09/09/2020 07:02

TEMPE, Ariz., Sept. 9, 2020 /PRNewswire/ --Benchmark Electronics, Inc. (NYSE:BHE), a global provider of engineering, design, and manufacturing services, and consumer genetic testing pioneersDnaNudge,today announced a key manufacturing partnership to deliver volume production of DnaNudge's rapid, lab-free reverse transcription polymerase chain reaction (RT-PCR) COVID-19 testing system. DnaNudge's ground-breaking consumer DNA testing innovation, which requires no lab and delivers results in just over an hour, has been re-engineered as a testing system to accurately detect COVID-19. In August, the U.K. government announced an order for 5.8 million CovidNudge testing kits to be rolled out in NHS hospitals and out-of-hospital locations across the U.K. starting September 2020, following successful validation.